-
Irving, M, Hoover-Fong, J, Bacino, C, Charrow, J, Cormier-Daire, V, Polgreen, L, Harmatz, P, Dickson, P, Bober, M, Mohnike, K, et al.
OP021: Vosoritide for children with achondroplasia: Growth velocity and pubertal milestones.
Genetics in Medicine
24(3)
:
s352 -s353
2022
view publication
-
Irving, M, Savarirayan, R, Arundel, P, Polgreen, L, Mohnike, K, Ozono, K, Saunders, M, Fisheleva, E, Huntsman-Labed, A, Day, J.
eP266: Associations between height and Health-Related Quality of Life (HRQoL) and functional independence in children with achondroplasia.
Genetics in Medicine
24(3)
:
s168 -s169
2022
view publication
-
Savarirayan, R, Baratela, W, Butt, T, Cormier-Daire, V, Irving, M, Miller, B, Mohnike, K, Ozono, K, Rosenfeld, R, Selicorni, A, et al.
eP204: Expert opinions regarding impact of achondroplasia on health-related quality of life and long-term effects of vosoritide: A modified Delphi study.
Genetics in Medicine
24(3)
:
s126 -s127
2022
view publication
-
Chan, ML, Qi, Y, Larimore, K, Cherukuri, A, Seid, L, Jayaram, K, Jeha, G, Fisheleva, E, Day, J, Huntsman-Labed, A, et al.
Pharmacokinetics and Exposure-Response of Vosoritide in Children with Achondroplasia..
Clin Pharmacokinet
61(2)
:
263 -280
2022
view publication
-
Reversade, B, Escande-Beillard, N, Dimopoulou, A, Fischer, B, Chng, SC, Li, Y, Shboul, M, Tham, P-Y, Kayserili, H, Al-Gazali, L, et al.
Author Correction: Mutations in PYCR1 cause cutis laxa with progeroid features..
Nat Genet
54(2)
:
213
2022
view publication